Non-invasive assessment of steatohepatitis indicates increased risk of coronary artery disease.

<h4>Introduction</h4>Fatty liver diseases (FLD), especially defined as metabolic dysfunction-associated FLD (MAFLD), is of growing importance for patients and health-care providers. Extrahepatic comorbidities, predominantly coronary artery disease (CAD), contribute to excess morbidity an...

Full description

Bibliographic Details
Main Authors: Sebastian Beer, Jonas Babel, Neef Martin, Valentin Blank, Johannes Wiegand, Thomas Karlas
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0286882